Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease
about
The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver diseaseObesity, fatty liver disease and intestinal microbiotaIntestinal microbiota in health and disease: role of bifidobacteria in gut homeostasisPediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsFarnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid MetabolismUrinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.The dormant blood microbiome in chronic, inflammatory diseases.Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA.Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluationBaseline Ultrasound and Clinical Correlates in Children with Cystic FibrosisCalcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical TrialLingonberries alter the gut microbiota and prevent low-grade inflammation in high-fat diet fed mice.Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats.Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell lineShared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.Innate Immunity and Inflammation in NAFLD/NASH.Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.Obesity and Obesity Related Diseases, Sugar Consumption and Bad Oral Health: A Fatal Epidemic Mixtures: The Pediatric and Odontologist Point of View.Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver DiseaseProtective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function.More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease.Pediatric non alcoholic fatty liver disease: more on novel treatment targets.A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice.Does increased serum d-lactate mean subclinical hyperpermeability of intestinal barrier in middle-aged nonobese males with OSA?Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis.Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease.Nutrition and Liver Disease.Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement.
P2860
Q26852498-0DC084B4-5B9A-4A17-9563-FBCD7454ABB1Q26997784-10F106F8-9ADA-4637-A4C4-6D0388516FB1Q27001712-051425A8-4488-4A35-BCDD-4B00E617FCB2Q28079432-9CFE8405-0AAA-4FAD-BA00-2870DECE9C47Q28821039-91C47898-295E-46A2-AD27-EEF6EE8EAB70Q33749444-687B3D4C-CE94-4871-89F4-8C1DA0D49124Q34474989-4ADB853C-FFC9-4717-BE8E-3ADD1EBB6357Q34499017-28B6823E-8583-4CD1-916D-F358D35512D3Q34647607-A181987D-824D-404C-961D-5E1E706F520EQ35058280-8B2C2BCF-F0F0-497D-AF31-234F253F42FBQ35670195-11534E6B-5AB4-4248-B267-726FB0DE252CQ35753377-8F0E3B1F-32D1-4588-83EE-7EA1510E0BF2Q35998233-5AF497B9-BBDB-4CA2-830D-5CCA7D3617CDQ36062584-B7672503-28B1-4505-A0C8-C52AB4FC09E3Q36101665-E40061F4-6D6B-4A9E-B9B5-BD46EAFF6B75Q36194038-07198C17-E289-4D71-A2C2-5B594965652FQ36732958-3B29C26E-F321-47FD-91DF-02573DABA8C0Q36849695-E45F0153-8929-4A19-ADDF-183F12346AF6Q36993965-907E8CCE-6C6A-4BD4-8A5A-F1D2AF285267Q37361703-FBC20D4D-6AD8-4FFF-A03A-8F97EA32277FQ38231064-3A565F44-45DB-484A-8062-F49F2696EF9BQ38298751-9A687FCD-ED5B-4AD6-8D30-7727E33F6692Q38721837-508AC800-54C5-48E2-883E-99D77AAC55CBQ39363389-5CDA9C28-A23A-44A6-9EAA-EDDB16A2FCBEQ41184332-2D13B63D-004A-4F18-8DAE-48A19D9F34B3Q41552497-2BC38A58-D036-45B0-84DC-5FA6FB8C0394Q41646462-C9B0B686-4BE2-4959-9440-B248129DC0E7Q42083796-4163CCBA-062E-4580-AF85-100E9AC4DC74Q43074168-F0E840CB-12B4-4F5F-AE71-E51357E46AEFQ46858371-257140E7-0A02-42FA-A9E9-E815B2E9D0E8Q47106910-0493DEBA-0F7F-4624-B8B5-C87FFD57EE41Q47180560-C8331266-84A2-4816-9674-7DECC01809A5Q49261126-7D444E9B-9F3F-4417-AB49-927B9E464C2DQ49289627-7C2B74C3-667A-4C66-BB90-BF7F6D40E562Q49592407-25CB234D-574F-4F07-94A6-4EFC02B92378Q51500710-A6FF4B61-FDAA-4345-BA5F-6A02C6B44C99
P2860
Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Microbiota and gut-liver axis: ...... obesity-related liver disease
@en
type
label
Microbiota and gut-liver axis: ...... obesity-related liver disease
@en
prefLabel
Microbiota and gut-liver axis: ...... obesity-related liver disease
@en
P2860
P1476
Microbiota and gut-liver axis: ...... obesity-related liver disease
@en
P2093
Alessio Fasano
Giulia Paolella
P2860
P304
P356
10.1097/MPG.0B013E318284ABB5
P407
P50
P577
2013-05-01T00:00:00Z